Onaka Hiroyasu
Department of Biotechnology, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Tokyo, Japan.
J Antibiot (Tokyo). 2017 Jul;70(8):865-870. doi: 10.1038/ja.2017.51. Epub 2017 Apr 26.
Streptomyces have the potential to produce more than 30 secondary metabolites; however, the expression of most metabolite biosynthetic gene clusters is cryptic or silent. Indeed, the expression of these genes is conditional and dependent on culture conditions. To activate such gene clusters, many methods have been developed. In this review, I describe two activation approaches developed in my laboratory: use of the activation mediator goadsporin and combined-culture. Goadsporin is a chemical substance isolated from Streptomyces sp. TP-A0584; it induces secondary metabolism and sporulation of many Streptomyces species. Combined-culture is a co-culture method to activate secondary metabolism in Streptomyces. The activator strains are mycolic acid-containing bacteria and ~90% of Streptomyces species show changes in secondary metabolism in combined-culture compared with pure culture. Thus, both methods may have applications in natural product-based drug discovery.
链霉菌有潜力产生30多种次级代谢产物;然而,大多数代谢物生物合成基因簇的表达是隐秘的或沉默的。事实上,这些基因的表达是有条件的,并且依赖于培养条件。为了激活此类基因簇,人们开发了许多方法。在这篇综述中,我描述了在我的实验室中开发的两种激活方法:使用激活介质刺孢霉素和混合培养。刺孢霉素是一种从链霉菌属TP-A0584中分离出的化学物质;它能诱导许多链霉菌物种的次级代谢和孢子形成。混合培养是一种激活链霉菌次级代谢的共培养方法。激活菌株是含分枝菌酸的细菌,与纯培养相比,约90%的链霉菌物种在混合培养中次级代谢会发生变化。因此,这两种方法在基于天然产物的药物发现中可能都有应用。